ArticleAntimicrobial agents and chemotherapy2017
Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular Methods.
Abstract readMulticenter Study
In one paragraph
Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.
0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
74 citing papers in PubMed.
- Susceptibility Profiles Among Sporothrix brasiliensis Genotypes in the Ongoing Zoonotic Sporotrichosis Epidemic in Brazil, Argentina and Paraguay.Mycopathologia · 2026Article
- Unique Genetic Clades and Frequent Zoonotic Transmission of Sporothrix brasiliensis with Reduced Itraconazole Susceptibility.Mycopathologia · 2026Article
- Genome variation of Sporothrix schenckii and Sporothrix brasiliensis.PLoS neglected tropical diseases · 2026Article
- In Vitro Antifungal Drug Susceptibility of Feline Sporothrix schenckii Complex Isolates, Thailand, 2023-2025.Emerging infectious diseases · 2026Article
- Establishment of epidemiological cutoff values for clinically relevantAntimicrobial agents and chemotherapy · 2026Article
- Investigating the Chemical, Antifungal, and Cytotoxic Properties of Cochlospermum vitifolium Leaves and Stem Bark Extracts.Chemistry & biodiversity · 2026Article
- Chemical modifications of diphenyl diselenide enhance its anti-Sporothrix spp. activity and exhibit synergism with itraconazole.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026Article
- Emergence of difficult-to-treat lymphocutaneous sporotrichosis? Analysis based on three cases with high and low MIC Sporothrix brasiliensis isolates.Revista do Instituto de Medicina Tropical de Sao Paulo · 2026Article
- Article
- Variability of clinical presentation and diagnostic challenges in osteoarticular sporotrichosis: a case series.Revista do Instituto de Medicina Tropical de Sao Paulo · 2026Article
- Cryptic Diversity and Ecological Overlap inJournal of fungi (Basel, Switzerland) · 2025Article
- Disseminated sporotrichosis caused byMedical mycology case reports · 2025Article
- Sporothrix brasiliensis Treatment Failure without Initial Elevated Itraconazole MICs in Felids at Border of Brazil.Emerging infectious diseases · 2025Article
- Prospective Uncontrolled Interventional Study of Itraconazole and β-Glucans (Veterinary sciences · 2025Article
- Targeted long-read sequencing analysis and antifungal susceptibility profiles of Sporothrix schenckii isolates from Thailand.PLoS neglected tropical diseases · 2025Article
- In Vitro Evidence for the Efficacy of Manuka Honey and Its Components Against the Major Human PathogenicPharmaceuticals (Basel, Switzerland) · 2025Article
- Therapeutic alternatives for sporotrichosis induced by wild-type and non-wild-type Sporothrix schenckii through in vitro and in vivo assessment of enilconazole, isavuconazole, posaconazole, and terbinafine.Scientific reports · 2025Article
- Sporotrichosis: an overview of the neglected disease reported worldwide in the last five years.Revista da Sociedade Brasileira de Medicina Tropical · 2025Review
- Zoonotic feline sporotrichosis: a small case cluster in Perth, Western Australia, and a review of previous feline cases from Australia.Australian veterinary journal · 2024Review
- Evidence of Clinical and Laboratory Correlation of Itraconazole Resistance inMicroorganisms · 2024Article
14 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
33 authors.
A Espinel-IngroffVCU Medical Center, Richmond, Virginia, USA victoria.ingroff@vcuhealth.org.
D P B AbreuUniversidade Federal Rural do Rio de Janeiro, Seropédica, Brazil.
R Almeida-PaesFundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Micologia, Rio de Janeiro, RJ, Brazil.
R S N BrilhanteSpecialized Medical Mycology Center, Federal University of Ceará, Fortaleza-CE, Brazil.
A ChakrabartiDepartment of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
A ChowdharyDepartment of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.ORCID 0000-0002-2028-7462
F HagenCanisius Wilhelmina Hospital, Centre of Expertise in Mycology, Nijmegen, The Netherlands.ORCID 0000-0002-5622-1916
S CórdobaDepartamento Micologia, Instituto Nacional de Enfermedades Infecciosas Dr. C. G. Malbrán, Buenos Aires, Argentina.
G M GonzalezUniversidad Autonóma de Nuevo León, Monterrey, Nuevo León, México.
N P GovenderNational Institute for Communicable Diseases and University of the Witwatersrand, Johannesburg, South Africa.ORCID 0000-0001-7869-9462
J GuarroMycology Unit Medical School, Universitat Rovira i Virgili, Reus, Spain.
E M JohnsonMycology Reference Laboratory, Public Health England, Bristol, United Kingdom.
S E KiddNational Mycology Reference Centre, SA Pathology, Adelaide, Australia.
S A PereiraFundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Micologia, Rio de Janeiro, RJ, Brazil.
A M RodriguesUniversidade Federal de São Paulo, São Paulo, Brazil.ORCID 0000-0003-0891-4563
S RozentalInstituto de Biofísica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
M W SzeszsInstituto Adolfo Lutz, Araçatuba, Rio Claro Laboratories, São Paulo, Brazil.
R Ballesté AlanizDepartamento de Laboratorio Clínico, Hospital de Clínicas Dr. M. Quintela, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
A BonifazHospital General de Mexico, Mexico City, Mexico.
L X BonfiettiInstituto Adolfo Lutz, Araçatuba, Rio Claro Laboratories, São Paulo, Brazil.
L P Borba-SantosInstituto de Biofísica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
J CapillaMycology Unit Medical School, Universitat Rovira i Virgili, Reus, Spain.
A L ColomboUniversidade Federal de São Paulo, São Paulo, Brazil.
M DolandeInstituto Nacional de Higiene Rafael Rangel, Caracas, Venezuela.
M G IslaDepartamento Micologia, Instituto Nacional de Enfermedades Infecciosas Dr. C. G. Malbrán, Buenos Aires, Argentina.
M S C MelhemInstituto Adolfo Lutz, Araçatuba, Rio Claro Laboratories, São Paulo, Brazil.
A C Mesa-ArangoGrupo de Investigación Dermatológica, Universidad de Antioquía, Medellín, Colombia.
M M E OliveiraFundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Micologia, Rio de Janeiro, RJ, Brazil.
M M PanizoInstituto Nacional de Higiene Rafael Rangel, Caracas, Venezuela.
Z Pires de CamargoUniversidade Federal de São Paulo, São Paulo, Brazil.
R M Zancope-OliveiraFundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Micologia, Rio de Janeiro, RJ, Brazil.
J F MeisCanisius Wilhelmina Hospital, Centre of Expertise in Mycology, Nijmegen, The Netherlands.ORCID 0000-0003-3253-6080
J TurnidgeUniversity of Adelaide, Adelaide, Australia.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clinical and Laboratory Standards Institute (CLSI) conditions for testing the susceptibilities of pathogenic
Indexed as
Amphotericin BAntifungal AgentsCaspofunginEchinocandinsFlucytosineHumansLipopeptidesMicrobial Sensitivity TestsNaphthalenesSporothrixSporotrichosisTerbinafineTriazolesAmphotericin BAntifungal AgentsCaspofunginEchinocandinsFlucytosineLipopeptidesNaphthalenesTerbinafineTriazolesantifungal resistanceECVsmolecular methodsSporothrix
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.